Inventor · disambiguated record
Robert S. Meissner
Also filed as: MEISSNER ROBERT · MEISSNER ROBERT S
40 granted patents·10 pending applications·576 citations·filing 1997–2019
97Inventor score
Top patents by PatentIndex Score
50 records- 0196US6048861AIntegrin receptor antagonistsMERCK & CO INC·Filed 1998·Granted Apr 11, 2000·100 cites·47 claims
- 0293US6066648AIntegrin receptor antagonistsMERCK & CO INC·Filed 1998·Granted May 23, 2000·67 cites·40 claims
- 0390US6410526B1αv integrin receptor antagonistsMERCK & CO INC·Filed 2000·Granted Jun 25, 2002·40 cites·28 claims
- 0490US6268378B1Integrin receptor antagonistsMERCK & CO INC·Filed 2000·Granted Jul 31, 2001·28 cites·30 claims
- 0589US6017926AIntegrin receptor antagonistsMERCK & CO INC·Filed 1998·Granted Jan 25, 2000·108 cites·48 claims
- 0688US7268153B2N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulatorsMERCK & CO INC·Filed 2005·Granted Sep 11, 2007·14 cites·13 claims
- 0788US6784190B2Integrin receptor antagonistsMERCK & CO INC·Filed 2001·Granted Aug 31, 2004·17 cites·23 claims
- 0886US7365202B2Polymorphs of an androgen receptor modulatorMERCK & CO INC·Filed 2006·Granted Apr 29, 2008·11 cites·31 claims
- 0984US7217720B217-heterocyclic-4-azasteroid derivatives as androgen receptor modulatorsMERCK & CO INC·Filed 2004·Granted May 15, 2007·20 cites·18 claims
- 1083US6472403B2αV integrin receptor antagonistsMERCK & CO INC·Filed 2001·Granted Oct 29, 2002·20 cites·14 claims
- 1182US10246456B2IRAK4 inhibiting agentsBIOGEN MA INC·Filed 2015·Granted Apr 2, 2019·5 cites·4 claims
- 1281US9278960B2Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2012·Granted Mar 8, 2016·4 cites·21 claims
- 1381US7625920B2Fluorinated 4-azasteroid derivatives as androgen receptor modulatorsMERCK & CO INC·Filed 2008·Granted Dec 1, 2009·2 cites·7 claims
- 1481US7186838B2Fluorinated 4-azasteroid derivatives as androgen receptor modulatorsMERCK & CO INC·Filed 2003·Granted Mar 6, 2007·16 cites·25 claims
- 1579US7745657B2D-homoandrosta-17-yl carbamate derivatives as selective glucocorticoid receptor ligandsMERCK SHARP & DOHME·Filed 2006·Granted Jun 29, 2010·4 cites·11 claims
- 1678US7153862B2αv integrin receptor antagonistsMERCK & CO INC·Filed 2003·Granted Dec 26, 2006·10 cites·5 claims
- 1777US10239849B2Cyanopyridine derivatives as liver X receptor beta agonists, compositions, and their useMERCK SHARP & DOHME·Filed 2016·Granted Mar 26, 2019·2 cites·13 claims
- 1876US9663506B2Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2016·Granted May 30, 2017·2 cites·16 claims
- 1976US9636337B2Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2016·Granted May 2, 2017·2 cites·30 claims
- 2076US7446110B217-Heterocyclic-4-azasteroid derivatives as androgen receptor modulatorsMERCK & CO INC·Filed 2004·Granted Nov 4, 2008·12 cites·22 claims
- 2175US6211184B1Integrin antagonistsMERCK & CO INC·Filed 1997·Granted Apr 3, 2001·21 cites·16 claims
- 2274US5981546AIntegrin antagonistsMERCK & CO INC·Filed 1997·Granted Nov 9, 1999·45 cites·17 claims
- 2373US10577367B2IRAK4 inhibiting agentsBIOGEN MA INC·Filed 2019·Granted Mar 3, 2020·1 cites·6 claims
- 2472US7629367B2N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulatorsMERCK & CO INC·Filed 2005·Granted Dec 8, 2009·1 cites·1 claims
- 2570US6693101B2αv integrin receptor antagonistsMERCK & CO INC·Filed 2001·Granted Feb 17, 2004·4 cites·1 claims
- 2667US10072003B2Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2015·Granted Sep 11, 2018·1 cites·8 claims
- 2760US7763659B2N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulatorsMERCK SHARP & DOHME·Filed 2007·Granted Jul 27, 2010·0 cites·1 claims
- 2859US6211191B1Integrin receptor antagonistsMERCK & CO INC·Filed 1998·Granted Apr 3, 2001·16 cites·23 claims
- 2958US7351698B2Androgen receptor modulators and methods of use thereofMERCK & CO INC·Filed 2004·Granted Apr 1, 2008·0 cites·1 claims
- 3058US2007088042A1Fluorinated 4-azasteroid derivatives as androgen receptor modulatorsMEISSNER ROBERT S·Filed 2006·Application pending·0 cites
- 3157US2008119503A1Androgen receptor modulators and methods of use thereofMEISSNER ROBERT S·Filed 2008·Application pending·0 cites
- 3247US2009275515A12-hydroxy-2-phenylthiophenylpropionamides as androgen receptor modulatorsKIM YUNTAE·Filed 2007·Application pending·0 cites
- 3344US7696217B217-acetamido-4-azasteroid derivatives as androgen receptor modulatorsMERCK SHARP & DOHME·Filed 2004·Granted Apr 13, 2010·0 cites·12 claims
- 3444US7482357B217-acetamido-4-azasteroid derivatives as androgen receptor modulatorsMERCK & CO INC·Filed 2004·Granted Jan 27, 2009·0 cites·17 claims
- 3544US7410977B2Fluorinated 4-azasteroids as androgen receptor modulatorsMERCK & CO INC·Filed 2005·Granted Aug 12, 2008·0 cites·6 claims
- 3644US6117842AFibrinogen receptor antagonistsMERCK & CO INC·Filed 1999·Granted Sep 12, 2000·3 cites·5 claims
- 3743US7605152B217-hydroxy-4-aza-androstan-3-ones as androgen receptor modulatorsMERCK & CO INC·Filed 2003·Granted Oct 20, 2009·0 cites·11 claims
- 3843US7109191B2Benzazepinone alpha vintegrin receptor antagonistsMERCK & CO INC·Filed 2002·Granted Sep 19, 2006·0 cites·9 claims
- 3942US11427561B2IRAK4 inhibiting agentsBIOGEN MA INC·Filed 2017·Granted Aug 30, 2022·0 cites·20 claims
- 4042US2008124402A1N-(Pyridin-3-Yl)-2-Phenylbutanamides As Androgen Receptor ModulatorsMERCK & CO INC·Filed 2005·Application pending·0 cites
- 4142US2009088458A1N-(Pyridin-4-Yl)-2-Phenylbutanamides as Androgen Receptor ModulatorsMEISSNER ROBERT S·Filed 2006·Application pending·0 cites
- 4241US8338472B2Hexahydrocyclopentyl[F]indazole carboxamides and derivatives thereof as selective glucocorticoid receptor modulatorsDANKULICH WILLIAM P·Filed 2009·Granted Dec 25, 2012·0 cites·11 claims
- 4341US8299048B2Hexahydrocyclopentyl[f]indazole sulfonamides and derivatives thereof as selective glucocorticoid receptor modulatorsDANKULICH WILLIAM P·Filed 2009·Granted Oct 30, 2012·0 cites·14 claims
- 4441US2005101593A1Phosphoric acid salt of an integrin receptor antagonistFiled 2001·Application pending·0 cites
- 4540US7329750B217-Acetamido-4-azasteroid derivatives as androgen receptor modulatorsMERCK & CO INC·Filed 2004·Granted Feb 12, 2008·0 cites·8 claims
- 4640US2007088028A117-Acetamido-4-azasteroid derivatives as androgen receptor modulatorsDANKULICH WILLIAM P·Filed 2004·Application pending·0 cites
- 4739US8119681B22-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydrocyclopenta [ƒ]indazole-5-YL]ethyl phenyl derivatives as glucocorticoid receptor ligandsBUNGARD CHRISTOPHER J·Filed 2007·Granted Feb 21, 2012·0 cites·17 claims
- 4836US2012214846A1Hexahydrocyclopentyl[f]indazole pyridyl ethanols and derivatives thereof as selective glucocorticoid receptor modulatorsMITCHELL HELEN J·Filed 2010·Application pending·0 cites
- 4933US2012214847A12-[1-PHENYL-5-HYDROXY-4a-SUBSTITUTED-HEXAHYDROCYCLOPENTA[F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDSBUNGARD CHRISTOPHER JAMES·Filed 2010·Application pending·0 cites
- 5027US2012172397A1HEXAHYDROCYCLOPENTA[f]INDAZOLE 5-YL ETHANOLS AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORSMITCHELL HELEN J·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert S. Meissner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →